blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2671871

EP2671871 - Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.08.2017
Database last updated on 18.11.2024
Most recent event   Tooltip25.08.2017No opposition filed within time limitpublished on 27.09.2017  [2017/39]
Applicant(s)For all designated states
BIOPROJET
30, rue des Francs Bourgeois
75003 Paris / FR
[N/P]
Former [2013/50]For all designated states
BIOPROJET
30, rue des Francs-Bourgeois
75003 Paris / FR
Inventor(s)01 / Berrebi-Bertrand, Isabelle
11 rue de Vergéal
35740 PACE / FR
02 / Billot, Xavier
5, rue Legraverend
35000 RENNES / FR
03 / Calmels, Thierry
24 rue des Erables
35520 MELESSE / FR
04 / Capet, Marc
Les Petites Rivières
35520 MELESSE / FR
05 / Krief, Stéphane
16 Boulevard de Sébastopol
35000 RENNES / FR
06 / Labeeuw, Olivier
9, rue Bellevue
35300 FOUGERES / FR
07 / Lecomte, Jeanne-Marie
30 rue des Francs Bourgeois
75003 PARIS / FR
08 / Levoin, Nicolas
35 rue de Rennes
35590 L'HERMITAGE / FR
09 / Ligneau, Xavier
4 Square Vivier Louis
35760 SAINT GREGOIRE / FR
10 / Robert, Philippe
9 chemin de la Reine Iseult
35740 PACE / FR
11 / Schwartz, Jean-Charles
9 villa Seurat
75014 PARIS / FR
 [2013/50]
Representative(s)Lavoix
2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[2016/42]
Former [2013/50]Blot, Philippe Robert Emile
Cabinet Lavoix
2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
Application number, filing date13170687.105.06.2013
[2013/50]
Priority number, dateEP2012030563205.06.2012         Original published format: EP 12305632
[2013/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2671871
Date:11.12.2013
Language:EN
[2013/50]
Type: B1 Patent specification 
No.:EP2671871
Date:19.10.2016
Language:EN
[2016/42]
Search report(s)(Supplementary) European search report - dispatched on:EP23.09.2013
ClassificationIPC:A61K45/06, C07D211/22, C07D211/46, A61K31/4545, A61K31/445, A61P9/00, A61P17/00, A61P11/00, C07D401/12
[2016/21]
CPC:
C07D401/12 (EP,US); A61K31/445 (EP,US); A61K31/4545 (EP,US);
A61K45/06 (US); A61P11/00 (EP); A61P17/00 (EP);
A61P9/00 (EP); C07D211/22 (EP,US); C07D211/46 (EP,US) (-)
Former IPC [2013/50]C07D211/46, C07D401/12, A61K31/4545, A61K31/445, A61P11/00, A61P9/00, A61P17/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/42]
Former [2013/50]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Neuartige (aza)Benzhydryletherderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als H4-Rezeptorliganden für therapeutische Anwendungen[2013/50]
English:Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications[2013/50]
French:Nouveaux dérivés d'éther (aza)benzhydryle, leur procédé de préparation et leur utilisation en tant que ligands du récepteur H4 pour applications thérapeutiques[2013/50]
Examination procedure23.01.2014Examination requested  [2014/10]
28.05.2014Amendment by applicant (claims and/or description)
12.05.2016Communication of intention to grant the patent
08.09.2016Fee for grant paid
08.09.2016Fee for publishing/printing paid
08.09.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.05.2016
Opposition(s)20.07.2017No opposition filed within time limit [2017/39]
Fees paidRenewal fee
22.06.2015Renewal fee patent year 03
30.06.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0243903  (RICHTER GEDEON VEGYESZET [HU]) [X] 1,3,8-12 * page 65; compound 4 * * claim 11 *;
 [A]WO2012041860  (BIOPROJET SOC CIV [FR], et al) [A] 1-15 * claims 1,8,15-19 *;
 [A]WO2005044807  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-15 * claims 1,29,30-58,116 *;
 [A]WO2009089234  (AUSPEX PHARMACEUTICALS [US], et al) [A] 1-15 * page 1, paragraph 2 * * example 1 *
 [X]  - JILEK J ET AL, "POTENTIAL ANTICONVULSANTS: 3-CHLOROBENZOPHENONE DERIVATIVES", COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, INSTITUTE OF ORGANIC CHEMISTRY & BIOCHEMISTRY, PRAGUE; CZ, (19890101), vol. 54, no. 8, ISSN 0010-0765, pages 2248 - 2260, XP001022860 [X] 1,3,8-12 * abstract * * page 2251; compound XVIII *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20020829), Database accession no. RN: 445394-44-5, XP002686332 [X] 1,3 * CAS RN: 445394-44-5 *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20020829), Database accession no. RN: 445391-64-0, XP002686333 [X] 1,3 * CAS RN: 445391-64-0 *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20080601), Database accession no. RN: 1024191-91-0, XP002686334 [X] 1,3 * CAS RN: 1024191-91-0 *
by applicant   - GALLI ET AL., NATURE, (2008), vol. 454, page 445
    - THURMOND ET AL., NATURE REV. DRUG DISC., (2008), vol. 7, page 41
    - BEL ET AL., BR J PHARMACOL, (2004), vol. 142, page 374
    - Handbook of Chemistry and Physics, CRC PRESS, INC., (1995), pages 2 - 25,2-26
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY, (1985), page 1418
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.